Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

H-Ras-specific activation of NF-κB protects NIH 3T3 cells against stimulus-dependent apoptosis

Abstract

Ras signaling involves the activation of several downstream pathways that exhibit isoform specificity. In this study, the basal and tumor necrosis factor α (TNFα)-induced activation of NF-κB has been examined in cells overexpressing H-Ras, K-Ras or N-Ras. Cells expressing H-Ras exhibited a basal κB activity that correlated with sustained IκB kinase activation and lower steady-state levels of IκBα in the cytosol. Upon activation with TNFα, the cells expressing the distinct Ras isoforms behaved similarly in terms of binding of nuclear proteins to a κB sequence and induction of a κB-dependent reporter gene. The basal activation of NF-κB in cells expressing H-Ras impaired staurosporine-induced apoptosis in these cells, through a mechanism that was NF-κB-dependent and inhibitable in the presence of z-VAD. Moreover, titration of caspase activation in response to staurosporine showed a significant resistance in cells expressing H-Ras when compared with the void vector or the N-Ras counterparts. These results indicate that the distinct Ras proteins have specific effects on the NF-κB pathway and that this action contributes to protect cells against apoptosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Arsura M, Mercurio F, Oliver AL, Thorgeirsson SS and Sonenshein GE . (2000). Mol. Cell. Biol., 20, 5381–5391.

  • Baldwin AS . (2001). J. Clin. Invest., 107, 241–246.

  • Cadoret A, Bertrand F, Baron-Delage S, Levy P, Courtois G, Gespach C, Capeau J and Cherqui G . (1997). Oncogene, 14, 1589–1600.

  • Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ and Der CJ . (1998). Oncogene, 17, 1395–1413.

  • Castrillo A, Diaz-Guerra MJ, Hortelano S, Martin-Sanz P and Bosca L . (2000). Mol. Cell. Biol., 20, 1692–1698.

  • Choy E, Chiu VK, Silletti J, Feoktistov M, Morimoto T, Michaelson D, Ivanov IE and Philips MR . (1999). Cell, 98, 69–80.

  • De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J, Cong R and Franzoso G . (2001). Nature, 414, 308–313.

  • Delhase M, Hayakawa M, Chen Y and Karin M . (1999). Science, 284, 309–313.

  • Diaz-Guerra MJM, Velasco M, Martin-Sanz P and Bosca L . (1996). J. Biol. Chem., 271, 30114–30120.

  • DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E and Karin M . (1997). Nature, 388, 548–554.

  • Downward J . (1996). Cancer Surv., 27, 87–100.

  • Fenwick C, Na SY, Voll RE, Zhong H, Im SY, Lee JW and Ghosh S . (2000). Science, 287, 869–873.

  • Finco TS and Baldwin ASJ . (1993). J. Biol. Chem., 268, 17676–17679.

  • Finco TS, Westwick JK, Norris JL, Beg AA, Der CJ and Baldwin ASJ . (1997). J. Biol. Chem., 272, 24113–24116.

  • Folgueira L, Algeciras A, MacMorran WS, Bren GD and Paya CV . (1996). J. Virol., 70, 2332–2338.

  • Fritz G and Kaina B . (2001). J. Biol. Chem., 276, 3115–3122.

  • Grana TM, Rusyn EV, Zhou H, Sartor CI and Cox AD . (2002). Cancer Res., 62, 4142–4150.

  • Henry DO, Moskalenko SA, Kaur KJ, Fu M, Pestell RG, Camonis JH and White MA . (2000). Mol. Cell. Biol., 20, 8084–8092.

  • Hortelano S, Zeini M, Castrillo A, Alvarez AM and Bosca L . (2002). Cell Death Differ., 9, 643–650.

  • Jo H, Zhang R, Zhang H, McKinsey TA, Shao J, Beauchamp RD, Ballard DW and Liang P . (2000). Oncogene, 19, 841–849.

  • Johnson L, Greenbaum D, Cichowski K, Mercer K, Murphy E, Schmitt E, Bronson RT, Umanoff H, Edelmann W, Kucherlapati R and Jacks T . (1997). Genes Dev., 11, 2468–2481.

  • Karin M . (1999). J. Biol. Chem., 274, 27339–27342.

  • Lander HM, Ogiste JS, Teng KK and Novogrodsky A . (1995). J. Biol. Chem., 270, 21195–21198.

  • Lee FS, Peters RT, Dang LC and Maniatis T . (1998). Proc. Natl. Acad. Sci. USA, 95, 9319–9324.

  • Lin YZ, Yao SY, Veach RA, Torgerson TR and Hawiger J . (1995). J. Biol. Chem., 270, 14255–14258.

  • Ludwig L, Kessler H, Wagner M, Hoang-Vu C, Dralle H, Adler G, Bohm BO and Schmid RM . (2001). Cancer Res., 61, 4526–4535.

  • Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin ASJ and Mayo MW . (2000). Mol. Cell. Biol., 20, 1626–1638.

  • Maeno E, Ishizaki Y, Kanaseki T, Hazama A and Okada Y . (2000). Proc. Natl. Acad. Sci. USA, 97, 9487–9492.

  • May MJ and Ghosh S . (1998). Immunol. Today, 19, 80–88.

  • Mayo MW, Norris JL and Baldwin AS . (2001). Methods Enzymol., 333, 73–87.

  • Mayo MW, Wang CY, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ and Baldwin ASJ . (1997). Science, 278, 1812–1815.

  • McCarthy SA, Samuels ML, Pritchard CA, Abraham JA and McMahon M . (1995). Genes Dev., 9, 1953–1964.

  • McFall A, Ulku A, Lambert QT, Kusa A, Rogers-Graham K and Der CJ . (2001). Mol. Cell. Biol., 21, 5488–5499.

  • Norris JL and Baldwin ASJ . (1999). J Biol. Chem., 274, 13841–13846.

  • Olson MF and Marais R . (2000). Semin. Immunol., 12, 63–73.

  • Pahan K, Liu X, McKinney MJ, Wood C, Sheikh FG and Raymond JR . (2000). J. Neurochem., 74, 2288–2295.

  • Prior IA and Hancock JF . (2001). J. Cell Sci., 114, 1603–1608.

  • Shields JM, Pruitt K, McFall A, Shaub A and Der CJ . (2000). Trends Cell Biol., 10, 147–154.

  • Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, Karin M and Lin A . (2001). Nature, 414, 313–317.

  • Umanoff H, Edelmann W, Pellicer A and Kucherlapati R . (1995). Proc. Natl. Acad. Sci. USA, 92, 1709–1713.

  • Wang CY, Mayo MW, Korneluk RG, Goeddel DV and Baldwin ASJ . (1998). Science, 281, 1680–1683.

  • Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T and Nathan C . (1992). Science, 256, 225–228.

  • Yan F, John SK and Polk DB . (2001). Cancer Res., 61, 8668–8675.

  • Yan J, Roy S, Apolloni A, Lane A and Hancock JF . (1998). J. Biol. Chem., 273, 24052–24056.

Download references

Acknowledgements

OM, AB and JLO were recipient of fellowships from Comunidad de Madrid, ISCIII and FIS (BEFI), respectively. This work was supported by Grants SAF2002-00783 and 08.3/0030/98 from CICYT and Comunidad de Madrid, respectively, to LB and by Grants BMC2001-0057 and 01/16 from Programa Nacional de PGC and ISCIII (intramural program), respectively, to JMR.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lisardo Boscá.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Millán, O., Ballester, A., Castrillo, A. et al. H-Ras-specific activation of NF-κB protects NIH 3T3 cells against stimulus-dependent apoptosis. Oncogene 22, 477–483 (2003). https://doi.org/10.1038/sj.onc.1206179

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206179

Keywords

This article is cited by

Search

Quick links